The CXCR2 chemokine receptor: A new target for gastric cancer therapy

被引：0
作者：
Kang, Wenyan [1 ]
Wang, Chengkun [1 ]
Wang, Minhui [1 ]
Liu, Meiqi [1 ]
Hu, Wei
Liang, Xiaoqiu [1 ]
Zhang, Yang [1 ]
机构：
[1] Univ South China, Hengyang Med Sch, Canc Res Inst, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China
来源：
CYTOKINE | 2024年 / 181卷
关键词：
CXCR2; Gastric cancer; Inflammation; Pathway; Therapy; TUMOR-ASSOCIATED MACROPHAGES; IMMATURE MYELOID CELLS; BREAST-CANCER; MELANOMA GROWTH; IN-VITRO; PROMOTES METASTASIS; HUMAN INTERLEUKIN-8; SUPPRESSOR-CELLS; POOR-PROGNOSIS; STEM-CELLS;
D O I：
10.1016/j.cyto.2024.156675
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Gastric cancer (GC) is one of the most common malignant tumors in the world, and current treatments are still based on surgery and drug therapy. However, due to the complexity of immunosuppression and drug resistance, the treatment of gastric cancer still faces great challenges. Chemokine receptor 2 (CXCR2) is one of the most common therapeutic targets in targeted therapy. As a G protein-coupled receptor, CXCR2 and its ligands play important roles in tumorigenesis and progression. The abnormal expression of these genes in cancer plays a decisive role in the recruitment and activation of white blood cells, angiogenesis, and cancer cell proliferation, and CXCR2 is involved in various stages of tumor development. Therefore, interfering with the interaction between CXCR2 and its ligands is considered a possible target for the treatment of various tumors, including gastric cancer.
引用
收藏
页数：11
相关论文
共 136 条
  • [21] CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow
    Eash, Kyle J.
    Greenbaum, Adam M.
    Gopalan, Priya K.
    Link, Daniel C.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (07) : 2423 - 2431
  • [22] Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
    Eruslanov, Evgeniy B.
    Bhojnagarwala, Pratik S.
    Quatromoni, Jon G.
    Stephen, Tom Li
    Ranganathan, Anjana
    Deshpande, Charuhas
    Akimova, Tatiana
    Vachani, Anil
    Litzky, Leslie
    Hancock, Wayne W.
    Conejo-Garcia, Jose R.
    Feldman, Michael
    Albeida, Steven M.
    Singhal, Sunil
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12) : 5466 - 5480
  • [23] PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
    Fabian, Kellsye P.
    Padget, Michelle R.
    Donahue, Renee N.
    Solocinski, Kristen
    Robbins, Yvette
    Allen, Clint T.
    Lee, John H.
    Rabizadeh, Shahrooz
    Soon-Shiong, Patrick
    Schlom, Jeffrey
    Hodge, James W.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [24] Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI [10.1001/jamaoncol.2016.5688, 10.1001/jamaoncol.2018.2706]
  • [25] Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
    Fu, Shengling
    Lin, Jiayuh
    [J]. ANTICANCER RESEARCH, 2018, 38 (11) : 6271 - 6279
  • [26] Impaired interleukin-8-and GROα-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia
    Fuhler, GM
    Knol, GJ
    Drayer, AL
    Vellenga, E
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (02) : 257 - 266
  • [27] Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
    Gabellini, Chiara
    Trisciuoglio, Daniela
    Desideri, Marianna
    Candiloro, Antonio
    Ragazzoni, Ylenia
    Orlandi, Augusto
    Zupi, Gabriella
    Del Bufalo, Donatella
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2618 - 2627
  • [28] Coordinated regulation of myeloid cells by tumours
    Gabrilovich, Dmitry I.
    Ostrand-Rosenberg, Suzanne
    Bronte, Vincenzo
    [J]. NATURE REVIEWS IMMUNOLOGY, 2012, 12 (04) : 253 - 268
  • [29] CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
    Ginestier, Christophe
    Liu, Suling
    Diebel, Mark E.
    Korkaya, Hasan
    Luo, Ming
    Brown, Marty
    Wicinski, Julien
    Cabaud, Olivier
    Charafe-Jauffret, Emmanuelle
    Birnbaum, Daniel
    Guan, Jun-Lin
    Dontu, Gabriela
    Wicha, Max S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (02) : 485 - 497
  • [30] A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
    Goldstein, Lori J.
    Mansutti, Mauro
    Levy, Christelle
    Chang, Jenny C.
    Henry, Stephanie
    Fernandez-Perez, Isaura
    Prausova, Jana
    Staroslawska, Elzbieta
    Viale, Giuseppe
    Butler, Beth
    McCanna, Susan
    Ruffini, Pier Adelchi
    Wicha, Max S.
    Schott, Anne F.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (02) : 265 - 275
12345678910